Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/123964
DC FieldValueLanguage
dc.contributor.authorHernandez, Men_US
dc.contributor.authorNovoa Medina,Yerayen_US
dc.contributor.authorFaner, Ren_US
dc.contributor.authorPalou, Een_US
dc.contributor.authorEsquerda, Aen_US
dc.contributor.authorCastelblanco, Een_US
dc.contributor.authorWägner, Ana M.en_US
dc.contributor.authorMauricio, Den_US
dc.date.accessioned2023-07-17T14:23:16Z-
dc.date.available2023-07-17T14:23:16Z-
dc.date.issued2022en_US
dc.identifier.issn1664-2392en_US
dc.identifier.urihttp://hdl.handle.net/10553/123964-
dc.description.abstractBackground: There is a controversy regarding Latent Autoimmune Diabetes in Adults (LADA) classification and whether it should be considered a slowly progressing form of type 1 (T1) diabetes (DM) or a distinct type of DM altogether. Methods: This cross-sectional study assessed major genes associated with T1DM (class II HLA, PTPN22 [rs2476601] and INS [rs689]) in patients with LADA, as compared with participants with T1DM (stratified according to age of diagnosis before or after 30) and T2DM. HLA genotyping of the DRB1, DQA1 and DQB1 loci was performed by reverse PCR sequence-specific oligonucleotides. HLA haplotypes were assigned according to those most frequently described in the European population. INS and PTPN22 SNPs were genotyped by real-time PCR. Results: A total of 578 participants were included: 248 with T1DM (70 diagnosed after the age of 30), 256 with T2DM and 74 with LADA. High risk HLA alleles were significantly more frequent in LADA than in T2DM, whereas the opposite was true for protective alleles. We found a lower frequency of the high-risk DRB1*04-DQB1*03:02-DQA1*03:01 haplotype in LADA (21.1%) than in the overall T1DM (34.7%) (p<0.05), whereas no differences were found between these groups for DRB1*03-DQB1*02:01-DQA1*05:01 or for protective alleles. Only 12% the overall T1DM group had no risk alleles vs 30% of LADA (p<0.0005). However, HLA allele distribution was similar in LADA and T1DM diagnosed after the age of 30. A total of 506 individuals (195 with T1DM [21 diagnosed after age 30] 253 with T2DM and 58 with LADA) were genotyped for the PTPN22 and INS SNPs. The G/A genotype of the PTPN22 rs2476601 was more frequent and the T/T genotype of the INS SNP rs689 was less frequent in T1DM compared to LADA. We did not find any significant differences in the frequency of the mentioned SNPs between LADA and T2DM, or between LADA and T1DM diagnosed after the age of 30. Conclusion: In this relatively small cross-sectional study, the genetic profile of subjects with LADA showed a similar T1DM-related risk allele distribution as in participants with T1DM diagnosed after the age of 30, but fewer risk alleles than those diagnosed before 30. Differences were present for HLA, as well as PTPN22 and INS genes.en_US
dc.languageengen_US
dc.relation.ispartofFrontiers in Endocrinologyen_US
dc.sourceFrontiers in Endocrinology [1664-2392], v. 13 (Agosto 2022)en_US
dc.subject32 Ciencias médicasen_US
dc.subject320502 Endocrinologíaen_US
dc.subject.otherLADA (latent autoimmune diabetes in adults)en_US
dc.subject.othergeneticsen_US
dc.subject.otherHLA class IIen_US
dc.subject.otherPTPN22en_US
dc.subject.otherType 1 diabetes mellitusen_US
dc.subject.otherINSen_US
dc.subject.otherAge of onseten_US
dc.titleGenetics: Is LADA just late onset type 1 diabetes?en_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.typeArticleen_US
dc.identifier.doi10.3389/fendo.2022.916698en_US
dc.identifier.scopus2-s2.0-85136573822-
dc.identifier.isiWOS:000844354300001-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.relation.volume13en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.description.numberofpages8en_US
dc.utils.revisionen_US
dc.date.coverdateAgosto 2022en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr1,278
dc.description.jcr5,2
dc.description.sjrqQ1
dc.description.jcrqQ1
dc.description.scieSCIE
dc.description.miaricds10,5
item.grantfulltextopen-
item.fulltextCon texto completo-
crisitem.author.deptGIR IUIBS: Diabetes y endocrinología aplicada-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptGIR IUIBS: Diabetes y endocrinología aplicada-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0002-7663-9308-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameNovoa Medina, Yeray-
crisitem.author.fullNameWägner, Anna Maria Claudia-
Appears in Collections:Artículos
Adobe PDF (407,16 kB)
Show simple item record

SCOPUSTM   
Citations

8
checked on Nov 24, 2024

WEB OF SCIENCETM
Citations

7
checked on Nov 17, 2024

Page view(s)

22
checked on May 18, 2024

Download(s)

13
checked on May 18, 2024

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.